Mouse Models

[1]  C. Vedeler,et al.  In situ characterization of the foam cells in early human atherosclerotic lesions. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

[2]  M. Bruzelius,et al.  Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Sprent,et al.  Antigen-Presenting Cells: Professionals and amateurs , 1995, Current Biology.

[4]  M. Rekhter,et al.  Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. , 1995, The American journal of pathology.

[5]  G. Schonfeld,et al.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. , 1995, The Journal of clinical investigation.

[6]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Qingbo Xu,et al.  Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. , 1995, International archives of allergy and immunology.

[8]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Fazio,et al.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.

[10]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Qiao,et al.  Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.

[12]  T. Drake,et al.  Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[14]  R. Hegele,et al.  Apolipoprotein E in Hyperlipidemia , 1994, Annals of Internal Medicine.

[15]  G. Hansson,et al.  Immune mechanisms in atherogenesis. , 1994, Annals of medicine.

[16]  N. Maeda,et al.  The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[18]  J. Bonnet,et al.  Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. , 1994, Circulation research.

[19]  P. Libby,et al.  Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a , 1994, Annals of the New York Academy of Sciences.

[20]  R. Hammer,et al.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.

[21]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[22]  E. Emeson,et al.  Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. , 1993, The American journal of pathology.

[23]  Qingbo Xu,et al.  Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. , 1993, The Journal of clinical investigation.

[24]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[25]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[26]  R. Hammer,et al.  Atherogenesis in transgenic mice expressing human apolipoprotein(a) , 1992, Nature.

[27]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[28]  A. Gown,et al.  Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[30]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[32]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  A. Lusis,et al.  Differential accumulation of intimal monocyte-macrophages relative to lipoproteins and lipofuscin corresponds to hemodynamic forces on cardiac valves in mice. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  V. Tertov,et al.  Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[35]  R. Mahley,et al.  Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism. , 1991, JAMA.

[36]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[37]  J. Pober,et al.  IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. , 1990, Journal of immunology.

[38]  G. Oberhuber,et al.  Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. , 1990, Clinical immunology and immunopathology.

[39]  E. Unanue,et al.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules. , 1990, Cell regulation.

[40]  S. Ylä-Herttuala,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[41]  D. Brown,et al.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. , 1990, Archives of pathology & laboratory medicine.

[42]  B. Paigen,et al.  Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. , 1990, Arteriosclerosis.

[43]  E. Unanue,et al.  Antigen presentation 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[45]  A. Becker,et al.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[46]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[47]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  O. Kocher,et al.  Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. , 1988, Atherosclerosis.

[49]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[50]  E. Emeson,et al.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. , 1988, The American journal of pathology.

[51]  M. Brown,et al.  Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. , 1987, Circulation.

[52]  J. D. van der Walt,et al.  An immunohistochemical analysis of human aortic fatty streaks. , 1987, Human pathology.

[53]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[54]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[55]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[56]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[57]  Y. Watanabe,et al.  The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia. , 1985, Atherosclerosis.

[58]  G. Gabbiani,et al.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.

[59]  D. Klurfeld,et al.  Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. , 1985, Archives of pathology & laboratory medicine.

[60]  H. Shio,et al.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[61]  H. Florey,et al.  Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. , 1958, The Journal of pathology and bacteriology.

[62]  G. Hansson,et al.  INTERFERON y INHIBITS BOTH PROLIFERATION AND EXPRESSION OF DIFFERENTIATION-SPECIFIC a-SMOOTH MUSCLE ACTIN IN ARTERIAL SMOOTH MUSCLE CELLS , 2003 .

[63]  J. Breslow,et al.  Apolipoprotein E and the apolipoprotein E-deficient mouse. , 1995, Annual review of nutrition.

[64]  Qingbo Xu,et al.  Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.

[65]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[66]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[67]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[68]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[69]  G. Hansson.  Immunological control mechanisms in plaque formation. , 1994, Basic research in cardiology.

[70]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[71]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[72]  J. Witztum,et al.  The role of oxidized LDL in atherosclerosis. , 1991, Advances in experimental medicine and biology.

[73]  R. Gerrity.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.